Lenskart Solutions company profile
Company profile
Lenskart Solutions has 19,201 employees and is headquartered in Gurugram, India.
Customers in India, Japan, Southeast Asia, the Middle East and other international markets buy the eyewear designed and sold by Lenskart Solutions Limited. Its range covers prescription glasses, sunglasses, goggles and contact lenses, and the company also carries out lens making alongside frame design and manufacturing. Products are sold under the Lenskart and Owndays names as well as sub-brands such as John Jacobs and Vincent Chase, through company-owned stores in India, websites, mobile apps and other channels, and the company offers home eye check-up services.
The company reported revenue of INR 88.1 billion in the fiscal year ended March 2026, up 32.5% from the previous year, and a net profit of INR 4.9 billion for the same period. It had 19,201 employees at the end of that period. Founded in 2008, Lenskart is headquartered in Gurugram, India.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- India
- Headquarters
- Vipul Tech Square, 122009, Gurugram
- Employees
- 19,201
- Chief executive
- Peyush Bansal
- Founded
- 2008
- Fiscal year
- April - March
- Listing
- LENSKART · NSE
- Currency
- INR
- ISIN
- INE956O01016
- Website
- lenskart.com
Lenskart Solutions and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Lenskart SolutionsLENSKART | India | $13.82B | 19,201 | 10.5% | 163.9 |
| Fisher And Paykel Healthcare CorpoFPH | Australia | $15.85B | 7,357 | 27.6% | 57.7 |
| Resmed CdiRMD | Australia | $33.23B | 11,370 | 34.0% | 22.3 |
| AnsellANN | Australia | $4.31B | 15,000 | 15.0% | 21.6 |
| HOYA7741 | Japan | $47.84B | 37,752 | 34.4% | 27.3 |
| SolventumSOLV | United States | $14.36B | 20,584 | 5.9% | 94.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.